Relation between interleukin-10 polymorphism and the efficacy of interferone–based therapies in HCV patients

A study of interleukin-10 (IL-10) promoter gene polymorphisms and response to therapy in chronic hepatitis C infection in children

Interleukin 28b polymorphisms and therapy response in chronic hepatitis C patients

The clinical significance of IL-10 and IL-12B gene Polymorphisms as predictor of response to HCV patients treated by peginterferon plus ribavirin

Single nucleotide polymorphism of IL-10 and IL- 28b as predictors to the response of interferon therapy in HCV infected children

Osteopontin gene polymorphism as marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C

Relation between Osteopontin gene polymorphism & its protein level and the efficacy of interferon-based therapies in HCV patients

Influence of vitamin D receptor gene polymorphisms on treatment of chronic HCV patients with interferon

Single nucleotide polymorphism analysis of Oligo adenylate synthatase and Interleukin 1 B genes in chronic HCV associated end stage liver disease

Association of transforming growth factor β1 gene polymorphism with natural clearance of hepatitis C virus